These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
435 related articles for article (PubMed ID: 19635928)
21. CFTR-dependent susceptibility of the cystic fibrosis-host to Pseudomonas aeruginosa. Grassmé H; Becker KA; Zhang Y; Gulbins E Int J Med Microbiol; 2010 Dec; 300(8):578-83. PubMed ID: 20951085 [TBL] [Abstract][Full Text] [Related]
22. Myriocin treatment of CF lung infection and inflammation: complex analyses for enigmatic lipids. Caretti A; Vasso M; Bonezzi FT; Gallina A; Trinchera M; Rossi A; Adami R; Casas J; Falleni M; Tosi D; Bragonzi A; Ghidoni R; Gelfi C; Signorelli P Naunyn Schmiedebergs Arch Pharmacol; 2017 Aug; 390(8):775-790. PubMed ID: 28439630 [TBL] [Abstract][Full Text] [Related]
23. Alterations in ceramide concentration and pH determine the release of reactive oxygen species by Cftr-deficient macrophages on infection. Zhang Y; Li X; Grassmé H; Döring G; Gulbins E J Immunol; 2010 May; 184(9):5104-11. PubMed ID: 20351190 [TBL] [Abstract][Full Text] [Related]
24. Lipids in cystic fibrosis. Becker KA; Henry B; Ziobro R; Riethmüller J; Gulbins E Expert Rev Respir Med; 2011 Aug; 5(4):527-35. PubMed ID: 21859272 [TBL] [Abstract][Full Text] [Related]
26. Expression of intestinal and lung alkaline sphingomyelinase and neutral ceramidase in cystic fibrosis f508del transgenic mice. Ohlsson L; Hjelte L; Hühn M; Scholte BJ; Wilke M; Flodström-Tullberg M; Nilsson A J Pediatr Gastroenterol Nutr; 2008 Nov; 47(5):547-54. PubMed ID: 18955860 [TBL] [Abstract][Full Text] [Related]
27. Acid sphingomyelinase inhibition protects mice from lung edema and lethal Staphylococcus aureus sepsis. Peng H; Li C; Kadow S; Henry BD; Steinmann J; Becker KA; Riehle A; Beckmann N; Wilker B; Li PL; Pritts T; Edwards MJ; Zhang Y; Gulbins E; Grassmé H J Mol Med (Berl); 2015 Jun; 93(6):675-89. PubMed ID: 25616357 [TBL] [Abstract][Full Text] [Related]
28. Homocysteine induces cerebral endothelial cell death by activating the acid sphingomyelinase ceramide pathway. Lee JT; Peng GS; Chen SY; Hsu CH; Lin CC; Cheng CA; Hsu YD; Lin JC Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():21-7. PubMed ID: 23665108 [TBL] [Abstract][Full Text] [Related]
29. Secretion of Acid Sphingomyelinase and Ceramide by Endothelial Cells Contributes to Radiation-Induced Intestinal Toxicity. Leonetti D; Estéphan H; Ripoche N; Dubois N; Aguesse A; Gouard S; Brossard L; Chiavassa S; Corre I; Pecqueur C; Neunlist M; Hadchity E; Gaugler MH; Mahé MM; Paris F Cancer Res; 2020 Jun; 80(12):2651-2662. PubMed ID: 32291318 [TBL] [Abstract][Full Text] [Related]
30. Alterations of the Ceramide Metabolism in the Peri-Infarct Cortex Are Independent of the Sphingomyelinase Pathway and Not Influenced by the Acid Sphingomyelinase Inhibitor Fluoxetine. Brunkhorst R; Friedlaender F; Ferreirós N; Schwalm S; Koch A; Grammatikos G; Toennes S; Foerch C; Pfeilschifter J; Pfeilschifter W Neural Plast; 2015; 2015():503079. PubMed ID: 26605090 [TBL] [Abstract][Full Text] [Related]
31. Pseudomonas aeruginosa microevolution during cystic fibrosis lung infection establishes clones with adapted virulence. Bragonzi A; Paroni M; Nonis A; Cramer N; Montanari S; Rejman J; Di Serio C; Döring G; Tümmler B Am J Respir Crit Care Med; 2009 Jul; 180(2):138-45. PubMed ID: 19423715 [TBL] [Abstract][Full Text] [Related]
32. Role of CD95 in pulmonary inflammation and infection in cystic fibrosis. Becker KA; Henry B; Ziobro R; Tümmler B; Gulbins E; Grassmé H J Mol Med (Berl); 2012 Sep; 90(9):1011-23. PubMed ID: 22314624 [TBL] [Abstract][Full Text] [Related]
33. Lipopolysaccharide (LPS), LPS-immune complexes and cytokines as inducers of pulmonary inflammation in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection. Kronborg G APMIS Suppl; 1995; 50():1-30. PubMed ID: 7756034 [TBL] [Abstract][Full Text] [Related]
35. PAF-mediated pulmonary edema: a new role for acid sphingomyelinase and ceramide. Göggel R; Winoto-Morbach S; Vielhaber G; Imai Y; Lindner K; Brade L; Brade H; Ehlers S; Slutsky AS; Schütze S; Gulbins E; Uhlig S Nat Med; 2004 Feb; 10(2):155-60. PubMed ID: 14704790 [TBL] [Abstract][Full Text] [Related]
36. [Correction of age-related changes in sphingolipid content in rat tissues by acid sphingomyelinase inhibition]. Har'kavenko VV; Storozhenko GB; Krasnikova OM; Babenko NO Fiziol Zh (1994); 2012; 58(1):56-60. PubMed ID: 22590738 [TBL] [Abstract][Full Text] [Related]
37. Cytokines and inflammatory mediators in cystic fibrosis. Courtney JM; Ennis M; Elborn JS J Cyst Fibros; 2004 Dec; 3(4):223-31. PubMed ID: 15698939 [TBL] [Abstract][Full Text] [Related]
38. An enzymatic assay for quantifying sphingomyelin in tissues and plasma from humans and mice with Niemann-Pick disease. He X; Chen F; Gatt S; Schuchman EH Anal Biochem; 2001 Jun; 293(2):204-11. PubMed ID: 11399033 [TBL] [Abstract][Full Text] [Related]
39. Improved pulmonary function by acid sphingomyelinase inhibition in a newborn piglet lavage model. von Bismarck P; Wistädt CF; Klemm K; Winoto-Morbach S; Uhlig U; Schütze S; Adam D; Lachmann B; Uhlig S; Krause MF Am J Respir Crit Care Med; 2008 Jun; 177(11):1233-41. PubMed ID: 18310483 [TBL] [Abstract][Full Text] [Related]